Salman Alharbi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Community Dwelling

Acute Lymphoblastic Leukemia

Randomized Controlled Trial

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia 38 (4) (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia 38 (4) (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia 38 (4) (2024)